Cardiovascular Effects of Preferred Home-based Exercise Training in Systolic Heart Failure

NCT ID: NCT02051712

Last Updated: 2023-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE3

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-28

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is I. To assess whether an individualized exercise training program is superior as compared to usual care with respect to exercise tolerance, II. to assess whether intervention tools that aim to increase exercise adherence are superior to an individualized exercise training alone with respect to exercise tolerance and long-term effects, and III. to identify biomarkers that that may be implemented into novel intervention tools aiming to increase exercise adherence in patients with chronic heart failure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Heart Failure

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

chronic heart failure exercise training preferred training prevention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual care

Usual car accruing to guidelines

Group Type NO_INTERVENTION

No interventions assigned to this group

Individualized training

Individualized exercise training program in addition to usual care

Group Type EXPERIMENTAL

exercise training

Intervention Type BEHAVIORAL

individualized exercise training

Individualized training plus adherence measures

Individualized exercise training plus measures to increase adherence

Group Type EXPERIMENTAL

exercise training

Intervention Type BEHAVIORAL

individualized exercise training

Adherence measures

Intervention Type BEHAVIORAL

Measures to increase adherence to exercise training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

exercise training

individualized exercise training

Intervention Type BEHAVIORAL

Adherence measures

Measures to increase adherence to exercise training

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women and men
* age 30-75 years
* chronic heart failure (NYHA II/III), left ventricular ejection fraction ≤40% be echo
* disease duration ≥ 6 month
* medical therapy accruing to guidelines (drug, devices, including CRT)
* written informed consent

Exclusion Criteria

* acute myocarditis
* instable angina
* heart surgery (e.g. ICD implantation, bypass) with last 6 weeks; CRT implantation within the last 6 months before study start
* severe cardiovascular events (myocardial infarction, cardiac decompensation, ICD shock, PCI due to instable angina) \< 6 weeks before study start
* preplanned hospital admission or intervention (e.g. planned revascularization, ICD implantation)
* uncorrected valve regurgitation or stenosis (\> second degree)
* safety concerns regarding or other reasons against exercise training
* severe depression
* regular exercise training within the last 6 weeks
* life expectancy \< 1 year
Minimum Eligible Age

30 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

OTHER

Sponsor Role collaborator

University Medicine Greifswald

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marcus Dörr, MD

Role: PRINCIPAL_INVESTIGATOR

University Greifswald

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Marcus Dörr

Greifswald, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marcus Dörr, MD

Role: CONTACT

Phone: +49 3834 8680500

Email: [email protected]

Stepahn B Felix, MD

Role: CONTACT

Phone: +4938348680500

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marcus Dörr, MD

Role: primary

Stephan B Felix, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DZHK-HGW-001

Identifier Type: -

Identifier Source: org_study_id